Richard Cairns

4.2k total citations · 2 hit papers
12 papers, 3.0k citations indexed

About

Richard Cairns is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Richard Cairns has authored 12 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 7 papers in Surgery and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Richard Cairns's work include Acute Myocardial Infarction Research (6 papers), Lipoproteins and Cardiovascular Health (6 papers) and Diabetes Treatment and Management (3 papers). Richard Cairns is often cited by papers focused on Acute Myocardial Infarction Research (6 papers), Lipoproteins and Cardiovascular Health (6 papers) and Diabetes Treatment and Management (3 papers). Richard Cairns collaborates with scholars based in United Kingdom, United States and Germany. Richard Cairns's co-authors include Carolyn H. McCabe, Sabina A. Murphy, David A. Morrow, Eugene Braunwald, Robert P. Giugliano, Elliott M. Antman, Andrew Charlesworth, James A. de Lemos, Eugene Braunwald and Christopher P. Cannon and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Richard Cairns

12 papers receiving 2.8k citations

Hit Papers

TIMI Risk Score for ST-Elevation Myocardial Infarction: A... 2000 2026 2008 2017 2000 2007 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Cairns United Kingdom 11 2.3k 1.2k 607 353 322 12 3.0k
Laura A. Demopoulos United States 26 3.5k 1.5× 1.8k 1.5× 1.3k 2.2× 207 0.6× 359 1.1× 39 4.3k
Raymond T. Yan Canada 32 2.8k 1.2× 864 0.7× 997 1.6× 196 0.6× 102 0.3× 95 3.5k
Mathieu Kernéis France 26 1.5k 0.7× 816 0.7× 300 0.5× 157 0.4× 327 1.0× 107 2.3k
Todd C. Villines United States 32 2.5k 1.1× 2.1k 1.8× 2.5k 4.2× 465 1.3× 189 0.6× 161 5.1k
Olivier Barthélémy France 23 2.0k 0.9× 1.1k 0.9× 319 0.5× 335 0.9× 431 1.3× 76 2.5k
Donata Lucci Italy 29 3.0k 1.3× 616 0.5× 406 0.7× 339 1.0× 72 0.2× 106 3.8k
Olaf Schouten Netherlands 34 2.9k 1.3× 2.7k 2.2× 439 0.7× 126 0.4× 183 0.6× 128 4.2k
Derek So Canada 26 1.9k 0.8× 1.2k 1.0× 405 0.7× 183 0.5× 305 0.9× 144 3.0k
Élodie Drouet France 18 1.8k 0.8× 727 0.6× 194 0.3× 488 1.4× 253 0.8× 30 2.5k
Jean-François Marquis Canada 27 1.7k 0.8× 946 0.8× 618 1.0× 61 0.2× 231 0.7× 62 2.5k

Countries citing papers authored by Richard Cairns

Since Specialization
Citations

This map shows the geographic impact of Richard Cairns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Cairns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Cairns more than expected).

Fields of papers citing papers by Richard Cairns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Cairns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Cairns. The network helps show where Richard Cairns may publish in the future.

Co-authorship network of co-authors of Richard Cairns

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Cairns. A scholar is included among the top collaborators of Richard Cairns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Cairns. Richard Cairns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Storey, Robert F., Richard C. Becker, Robert A. Harrington, et al.. (2011). Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes. European Heart Journal. 32(23). 2945–2953. 133 indexed citations
2.
Doehner, Wolfram, Erland Erdmann, Richard Cairns, et al.. (2011). Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: An analysis of the PROactive study population. International Journal of Cardiology. 162(1). 20–26. 162 indexed citations
3.
Pfister, Roman, Richard Cairns, Erland Erdmann, & Christian Schneider. (2011). A clinical risk score for heart failure in patients with type 2 diabetes and macrovascular disease: An analysis of the PROactive study. International Journal of Cardiology. 162(2). 112–116. 31 indexed citations
4.
Ray, Kausik K., Babak Nazer, Richard Cairns, C. Michael Gibson, & Christopher P. Cannon. (2010). Association between percutaneous coronary intervention and long-term C-reactive protein levels in patients with acute coronary syndromes. Journal of Thrombosis and Thrombolysis. 30(1). 10–13. 6 indexed citations
5.
Ray, Kausik K., Christopher P. Cannon, Richard Cairns, et al.. (2009). Prognostic Utility of ApoB/AI, Total Cholesterol/HDL, Non-HDL Cholesterol, or hs-CRP as Predictors of Clinical Risk in Patients Receiving Statin Therapy After Acute Coronary Syndromes. Arteriosclerosis Thrombosis and Vascular Biology. 29(3). 424–430. 115 indexed citations
6.
Wiviott, Stephen D., Dietmar Trenk, Andrew L. Frelinger, et al.. (2007). Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention. Circulation. 116(25). 2923–2932. 623 indexed citations breakdown →
7.
Mega, Jessica L., David A. Morrow, Christopher P. Cannon, et al.. (2006). Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy. Journal of Thrombosis and Thrombolysis. 22(1). 71–76. 20 indexed citations
8.
Ray, Kausik K., Christopher P. Cannon, Richard Cairns, et al.. (2005). Relationship Between Uncontrolled Risk Factors and C-Reactive Protein Levels in Patients Receiving Standard or Intensive Statin Therapy for Acute Coronary Syndromes in the PROVE IT-TIMI 22 Trial. Journal of the American College of Cardiology. 46(8). 1417–1424. 92 indexed citations
9.
Ray, Kausik K., Christopher P. Cannon, Carolyn H. McCabe, et al.. (2005). Early and Late Benefits of High-Dose Atorvastatin in Patients With Acute Coronary Syndromes. Journal of the American College of Cardiology. 46(8). 1405–1410. 225 indexed citations
10.
Cannon, Christopher P., Eugene Braunwald, Carolyn H. McCabe, et al.. (2005). Antibiotic Treatment ofChlamydia pneumoniaeafter Acute Coronary Syndrome. New England Journal of Medicine. 352(16). 1646–1654. 212 indexed citations
11.
Morrow, David A., Elliott M. Antman, Robert P. Giugliano, et al.. (2001). A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy. The Lancet. 358(9293). 1571–1575. 216 indexed citations
12.
Morrow, David A., Elliott M. Antman, Andrew Charlesworth, et al.. (2000). TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation. Circulation. 102(17). 2031–2037. 1141 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026